{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:39:38Z","timestamp":1770046778803,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81201762"],"award-info":[{"award-number":["81201762"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National High Technology Research and Development Program of China","award":["2015YJS164"],"award-info":[{"award-number":["2015YJS164"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s11010-016-2707-0","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T09:22:48Z","timestamp":1462267368000},"page":"193-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo"],"prefix":"10.1007","volume":"416","author":[{"given":"Jingsi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diandian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honggang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanhui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,3]]},"reference":[{"issue":"9822","key":"2707_CR1","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379(9822):1245\u20131255","journal-title":"Lancet"},{"issue":"Suppl 3","key":"2707_CR2","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/S1590-8658(10)60507-5","volume":"42","author":"H Nordenstedt","year":"2010","unstructured":"Nordenstedt H, White DL, El-Serag HB (2010) The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 42(Suppl 3):S206\u2013S214. doi: 10.1016\/S1590-8658(10)60507-5","journal-title":"Dig Liver Dis"},{"key":"2707_CR3","unstructured":"Theise ND, Chen CJ, Kew MC (2014) Liver cancer. World Cancer Report, pp 577\u2013593"},{"issue":"3","key":"2707_CR4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.transproceed.2013.02.101","volume":"45","author":"SN Sintra","year":"2013","unstructured":"Sintra SN, Tom\u00e9 L, Cipriano MA, Bento C, Furtado E (2013) Long-term outcome of the first 150 liver transplant recipients: a single-center experience. Transpl Proc 45(3):1119\u20131121","journal-title":"Transpl Proc"},{"issue":"11","key":"2707_CR5","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","volume":"25","author":"G Chamberlain","year":"2007","unstructured":"Chamberlain G, Fox J, Ashton B, Middleton J (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25(11):2739\u20132749","journal-title":"Stem Cells"},{"issue":"6859","key":"2707_CR6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/35102181","volume":"414","author":"P Bianco","year":"2001","unstructured":"Bianco P, Robey PG (2001) Stem cells in tissue engineering. Nature 414(6859):118\u2013121","journal-title":"Nature"},{"issue":"7","key":"2707_CR7","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1053\/j.gastro.2008.03.015","volume":"134","author":"TK Kuo","year":"2008","unstructured":"Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC, Yang VW et al (2008) Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134(7):2111\u20132121","journal-title":"Gastroenterology"},{"issue":"1\u20132","key":"2707_CR8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jneuroim.2009.10.017","volume":"218","author":"S Gunnarsson","year":"2010","unstructured":"Gunnarsson S, Bexell D, Svensson A, Siesj\u00f6 P, Darabi A, Bengzon J (2010) Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFN-\u03b3-tansduced tumor cell immunotherapy of experimental glioma. J Neuroimmunol 218(1\u20132):140\u2013144","journal-title":"J Neuroimmunol"},{"issue":"2","key":"2707_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2009.08.031","volume":"290","author":"P Gao","year":"2010","unstructured":"Gao P, Ding Q, Wu Z, Jiang H, Fang Z (2010) Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma. Cancer Lett 290(2):157\u2013166","journal-title":"Cancer Lett"},{"issue":"9","key":"2707_CR10","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1634\/stemcells.2008-0084","volume":"26","author":"C Ren","year":"2008","unstructured":"Ren C, Kumar S, Chanda D, Chen J, Mountz JD, Ponnazhagan S (2008) Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model. Stem Cells 26(9):2332\u20132338","journal-title":"Stem Cells"},{"issue":"1","key":"2707_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4149\/av_2014_01_3","volume":"58","author":"E \u010eurinikov\u00e1","year":"2014","unstructured":"\u010eurinikov\u00e1 E, Ku\u010derov\u00e1 L, Mat\u00fa\u0161kov\u00e1 M (2014) Mesenchymal stromal cells retrovirally transduced with prodrug-converting genes are suitable vehicles for cancer gene therapy. Acta Virol 58(1):1\u201313","journal-title":"Acta Virol"},{"issue":"10","key":"2707_CR12","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1158\/0008-5472.CAN-08-4698","volume":"69","author":"MR Loebinger","year":"2009","unstructured":"Loebinger MR, Eddaoudi A, Davies D, Janes SM (2009) Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res 69(10):4132\u20134142","journal-title":"Cancer Res"},{"issue":"4","key":"2707_CR13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/mt.2008.3","volume":"16","author":"X Chen","year":"2008","unstructured":"Chen X, Lin X, Zhao J, Shi W, Zhang H, Wang Y et al (2008) A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs. Mol Ther 16(4):749\u2013756","journal-title":"Mol Ther"},{"issue":"5","key":"2707_CR14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/gt.2010.170","volume":"18","author":"SH Seo","year":"2011","unstructured":"Seo SH, Kim KS, Park SH, Suh YS, Kim SJ, Jeun SS et al (2011) The effects of mesenchymal stem cells injected via different routes on modified IL-12-meidated antitumor activity. Gene Ther 18(5):488\u2013495","journal-title":"Gene Ther"},{"issue":"1","key":"2707_CR15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1128\/JVI.68.1.346-351.1994","volume":"68","author":"MH Noteborn","year":"1994","unstructured":"Noteborn MH, Todd D, Verschueren CA, de Gauw HW, Curran WL, Veldkamp S et al (1994) A single chicken anemia virus protein induces apoptosis. J Virol 68(1):346\u2013351","journal-title":"J Virol"},{"issue":"8","key":"2707_CR16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s10495-012-0720-7","volume":"17","author":"P Taebunpakul","year":"2012","unstructured":"Taebunpakul P, Syan BS, Flinterman M, Klanrit P, G\u00e4ken J, Odell EW et al (2012) Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and \u03b4Np73 isoforms through ubiquitin ligase PIR2. Apoptosis 17(8):762\u2013776","journal-title":"Apoptosis"},{"issue":"19","key":"2707_CR17","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1242\/jcs.02580","volume":"118","author":"S Maddika","year":"2005","unstructured":"Maddika S, Booy EP, Johar D, Gibson SB, Ghavami S, Los M (2005) Cancer-specific toxicity of Apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur7-dependent pathway. J Cell Sci 118(19):4485\u20134493","journal-title":"J Cell Sci"},{"issue":"30","key":"2707_CR18","doi-asserted-by":"crossref","first-page":"27729","DOI":"10.1074\/jbc.M303114200","volume":"278","author":"AA Danen-Van Oorschot","year":"2003","unstructured":"Danen-Van Oorschot AA, Zhang YH, Leliveld SR, Rohn JL, Seelen MC, Bolk MW et al (2003) Importance of nuclear localization of Apoptin for tumor-specific induction of apoptosis. J Biol Chem 278(30):27729\u201327736","journal-title":"J Biol Chem"},{"issue":"12","key":"2707_CR19","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1002\/ijc.23884","volume":"123","author":"HV Kuusisto","year":"2008","unstructured":"Kuusisto HV, Wagstaff KM, Alvisi G, Jans DA (2008) The C-terminus of Apoptin represents a unique tumor cell-enhanced nuclear targeting module. Int J Cancer 123(12):2965\u20132969","journal-title":"Int J Cancer"},{"key":"2707_CR20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.sbi.2014.03.003","volume":"27","author":"BC Berks","year":"2014","unstructured":"Berks BC, Lea SM, Stansfeld PJ (2014) Structural biology of tat protein transport. Curr Opin Struct Biol 27:32\u201337","journal-title":"Curr Opin Struct Biol"},{"issue":"6","key":"2707_CR21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1359-6446(03)02623-0","volume":"8","author":"VP Torchilin","year":"2003","unstructured":"Torchilin VP, Lukyanov AN (2003) Peptide and protin drug delivery to and into tumors: challenges and solutions. Drug Discov Today 8(6):259\u2013266","journal-title":"Drug Discov Today"},{"issue":"13","key":"2707_CR22","first-page":"3603","volume":"62","author":"M Studeny","year":"2002","unstructured":"Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62(13):3603\u20133608","journal-title":"Cancer Res"},{"issue":"5","key":"2707_CR23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1742-7843.2004.pto950502.x","volume":"95","author":"M Kassem","year":"2004","unstructured":"Kassem M, Kristiansen M, Abdallah BM (2004) Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol 95(5):209\u2013214","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"2707_CR24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.0022-202X.2005.10123.x","volume":"10","author":"N Wakisaka","year":"2005","unstructured":"Wakisaka N, Taira Y, Ishikawa M, Nakamizo Y, Kobayashi K, Uwabu M et al (2005) Effectiveness of finasteride on patients with male pattern baldness who have different androgen receptor gene polymorphism. J Investig Dermatol Symp Proc 10(3):293\u2013294","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"6","key":"2707_CR25","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1634\/stemcells.2007-1006","volume":"26","author":"G Lazennec","year":"2008","unstructured":"Lazennec G, Jorgensen C (2008) Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells 26(6):1387\u20131394","journal-title":"Stem Cells"},{"issue":"21","key":"2707_CR26","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/jnci\/djh299","volume":"96","author":"M Studeny","year":"2004","unstructured":"Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN et al (2004) Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96(21):1593\u20131603","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2707_CR27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1470-2045(08)70099-8","volume":"9","author":"MF Corsten","year":"2008","unstructured":"Corsten MF, Shah K (2008) Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare. Lancet Oncol 9(4):376\u2013384","journal-title":"Lancet Oncol"},{"issue":"8","key":"2707_CR28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nbt0806-942","volume":"24","author":"V Ozdemir","year":"2006","unstructured":"Ozdemir V, Williams-Jones B, Glatt SJ, Tsuang MT, Lohr JB, Reist C (2006) Shifting emphasis from pharmacogenomics to theragnostics. Nat Biotechnol 24(8):942\u2013946. doi: 10.1038\/nbt0806-942","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2707_CR29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1532\/IJH97.06230","volume":"86","author":"B Hall","year":"2007","unstructured":"Hall B, Dembinski J, Sasser AK, Studeny M, Andreeff M, Marini F (2007) Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Int J Hematol 86(1):8\u201316","journal-title":"Int J Hematol"},{"issue":"7","key":"2707_CR30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/jnci\/dji088","volume":"97","author":"D Wolf","year":"2005","unstructured":"Wolf D, Rumpold H, Koeck R, Gunsilius E (2005) Re: mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 97(7):540\u2013541","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"2707_CR31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1634\/stemcells.2003-0106","volume":"24","author":"A Damme Van","year":"2006","unstructured":"Van Damme A, Thorrez L, Ma L, Vandenburgh H, Eyckmans J, Dell\u2019Accio F, De Bari C et al (2006) Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells. Stem Cells 24(4):896\u2013907","journal-title":"Stem Cells"},{"issue":"6","key":"2707_CR32","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jgm.731","volume":"7","author":"J Hoelters","year":"2005","unstructured":"Hoelters J, Ciccarella M, Drechsel M, Geissler C, G\u00fclkan H, B\u00f6cker W et al (2005) Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells. J Gene Med 7(6):718\u2013728","journal-title":"J Gene Med"},{"issue":"21","key":"2707_CR33","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/gt.2008.101","volume":"15","author":"C Ren","year":"2008","unstructured":"Ren C, Kumar S, Chanda D, Kallman L, Chen L, Mountz JD et al (2008) Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model. Gene Ther 15(21):1446\u20131453","journal-title":"Gene Ther"},{"issue":"23","key":"2707_CR34","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1158\/1078-0432.CCR-09-1292","volume":"15","author":"EK Mader","year":"2009","unstructured":"Mader EK, Maeyama Y, Lin Y, Butler GW, Russell HM, Galanis E et al (2009) Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model. Clin Cancer Res 15(23):7246\u20137255","journal-title":"Clin Cancer Res"},{"issue":"13","key":"2707_CR35","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1158\/0008-5472.CAN-06-4024","volume":"67","author":"L Kucerova","year":"2007","unstructured":"Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C (2007) Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 67(13):6304\u20136313","journal-title":"Cancer Res"},{"issue":"12","key":"2707_CR36","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1073\/pnas.0806647106","volume":"106","author":"LS Sasprotas","year":"2009","unstructured":"Sasprotas LS, Kasmieh R, Wakimoto H, Hingtgen S, van de Water JA, Mohapatra G (2009) Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci USA 106(12):4822\u20134827","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2707_CR37","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1110\/ps.23401","volume":"10","author":"S Hakansson","year":"2001","unstructured":"Hakansson S, Jacobs A, Caffrey M (2001) Heparin binding by the HIV-1 tat protein transduction domain. Protein Sci 10(10):2138\u20132139","journal-title":"Protein Sci"},{"issue":"3","key":"2707_CR38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jconrel.2004.07.023","volume":"99","author":"L Hyndman","year":"2004","unstructured":"Hyndman L, Lemoine JL, Huang L, Porteous DJ, Boyd AC, Nan X (2004) HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. J Control Release 99(3):435\u2013444","journal-title":"J Control Release"},{"key":"2707_CR39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exer.2013.12.016","volume":"120","author":"L Liu","year":"2014","unstructured":"Liu L, Yu R, Shi Y, Dai Y, Zeng Z, Guo X et al (2014) Transduced protein transduction domain linker HSP27 protected LECs against UVB radiation-induced damage. Exp Eye Res 120:36\u201342","journal-title":"Exp Eye Res"},{"issue":"3","key":"2707_CR40","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1158\/1535-7163.MCT-05-0334","volume":"5","author":"S Komarova","year":"2006","unstructured":"Komarova S, Kawakami Y, Stoff-Khalili MA, Curiel DT, Pereboeva L (2006) Mesenchymal Progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther 5(3):755\u2013766","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"2707_CR41","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s13277-013-1165-5","volume":"35","author":"L Hou","year":"2014","unstructured":"Hou L, Wang X, Zhou Y, Ma H, Wang Z, He J et al (2014) Inhibitory effect and mechanism of mesenchymal stem cells on liver cancer cells. Tumour Biol 35(2):1239\u20131250","journal-title":"Tumour Biol"},{"issue":"4","key":"2707_CR42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s000180050322","volume":"55","author":"GJ Maestroni","year":"1999","unstructured":"Maestroni GJ, Hertens E, Galli P (1999) Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice. Cell Mol Life Sci 55(4):663\u2013667","journal-title":"Cell Mol Life Sci"},{"issue":"14","key":"2707_CR43","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.gt.3302276","volume":"11","author":"K Nakamura","year":"2004","unstructured":"Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H et al (2004) Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 11(14):1155\u20131164","journal-title":"Gene Ther"},{"issue":"1","key":"2707_CR44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3892\/ijmm.2015.2413","volume":"37","author":"JS Heo","year":"2016","unstructured":"Heo JS, Choi Y, Kim HS, Kim HO (2016) Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med 37(1):115\u2013125","journal-title":"Int J Mol Med"},{"issue":"4","key":"2707_CR45","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/cr.2008.40","volume":"18","author":"L Qiao","year":"2008","unstructured":"Qiao L, Xu Z, Zhao T, Zhao Z, Shi M, Zhao RC et al (2008) Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res 18(4):500\u2013507","journal-title":"Cell Res"},{"issue":"4","key":"2707_CR46","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.3892\/mmr.2015.4076","volume":"12","author":"Q You","year":"2015","unstructured":"You Q, Yao Y, Zhang Y, Fu S, Du M, Zhang G (2015) Effect of targeted ovarian cancer therapy using amniotic fluid mesenchymal stem cells transfected with enhanced green fluorescent protein-human interleukin-2 in vivo. Mol Med Rep 12(4):4859\u20134866","journal-title":"Mol Med Rep"},{"key":"2707_CR47","author":"G Marone","year":"2015","unstructured":"Marone G, Varricchi G, Loffredo S, Granata F (2015) Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangigenesis. Eur J Pharmacol. doi: 10.1016\/j.ejphar.2015.03.088","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"2707_CR48","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1007\/s13277-014-2952-3","volume":"36","author":"H Akrami","year":"2015","unstructured":"Akrami H, Aminzadeh S, Fallahi H (2015) Inhibitory effect of ibuprofen on tumor survival and angiogenesis in gastric cancer cell. Tumour Biol 36(5):3237\u20133243","journal-title":"Tumour Biol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-016-2707-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-016-2707-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-016-2707-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T10:36:49Z","timestamp":1600511809000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-016-2707-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":48,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["2707"],"URL":"https:\/\/doi.org\/10.1007\/s11010-016-2707-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}